Immunohistochemical localisation of telomerase in mammary adenocarcinoma in bitches

• Autorzy: Nowak M , Madej J.A. , Dziegiel P. , Dzimira S.
• Języki publikacji: EN

Abstrakty

EN

The studies were aimed at immunohistochemical determination of telomerase expression in cells of primary adenocarcinomas in mammary glands of bitches. Moreover, it was aimed at comparing the obtained results with an extent of Ki-67 antigen expression, which reflects the proliferation rate of tumour cells. Material for the studies was sampled during surgery in 35 bitches of various breed, ranging in age from 5 to 14 years, which developed mammary tumour. Using histopathology, the tumours were verified as representing adenocarcinomas. This was followed by immunohistochemical reactions for the detection of telomerase and Ki-67 expression. The obtained preparations were photographed and the images were subjected to computer-assisted analysis using the MultiScaneBase V 14.02 software. The obtained mean positive correlation (r = 0.26) between the expression of Ki-67 proliferative antigen and that of telomerase in mammary adenocarcinoma of bitches points at the involvement of the enzyme in neoplastic processes in animals, in an analogy to breast cancers in women.

Słowa kluczowe

EN

adenocarcinoma; immunohistochemical reaction; mammary adenocarcinoma; veterinary medicine; telomerase; neoplastic process; mammary gland; telomerase expression; animal disease; mammary tumour; bitch; dog

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 1
• Opis fizyczny: p.113-117,fig.,ref.

Twórcy

autor

Nowak M

• University of Environmental and Life Sciences, 50-375 Wroclaw, Poland

autor

Madej J.A.

autor

Dziegiel P.

autor

Dzimira S.

Bibliografia

• 1. Allsopp R., Chang E., Kashefi-Aazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., Harley C.B.: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995, 220, 194-200.
• 2. Bailey S.M., Murnane J.P.: Telomeres, chromosome instability and cancer. Nucleic Acids Res 2006, 34, 2408-2417.
• 3. Blackburn E.H.: Telomere states and cell fates. Nature 2000, 408, 53-56.
• 4. Blasco M.A.: Telomeres and human disease: ageing, cancer and beyond. Nat Rev Gen 2005, 6, 611-622.
• 5. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B.: Extension of life span by introduction of telomerase into normal human cells. Science 1998, 279, 349-352.
• 6. Bryan T.M., Englezou A., Gupta J., Bacchetti S., Reddel R.R.: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14, 4240-4248.
• 7. Dzimira S., Madej J.A., Nowak M.: Immunohistochemical location of telomerase in lymphoma malignum in dogs. Med Weter 2006, 62, 215- 219.
• 8. Fenq J., Funk W.O., Wang S.S., Weinrich S.L., Avilion A.A., Chiu G.P., Adams R.R., Chanq E., Allsopp R.C., Yu J.: The RNA component of human telomerase. Science 1995, 269, 1236-1241.
• 9. Harley C.B., Vaziri H., Counter C.M., Allsopp R.C.: The telomere hypothesis of cellular aging. Exp Gerontol 1992, 27, 375-382.
• 10. Harley C.B.: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991, 256, 271- 282.
• 11. Herbert B.S., Wright W.E., Shay J.W.: Telomerase and breast cancer. Breast Cancer Res 2001, 3, 146-149.
• 12. Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A.F., Hiyama K., Piatyszek M.A., Shay J.W.: Telomerase activity in human breast tumors. J Natl Cancer Inst 1996, 88, 116-122.
• 13. Hiyama K., Hiyama E., Ishioka S., Yamakido M., Inai K., Gazdar A.F., Piatyszek M.A., Shay J.W.: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995, 87, 895-902.
• 14. Ikeda S., Shibata T., Eishi Y., Takizawa T., Koike M.: Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining method. Pathol Int 2003, 11, 762-768.
• 15. Jiang X.R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A. G., Wahl G.M., Tlsty T.D., Chiu C.P.: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Gen 1999, 21, 111-114.
• 16. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W.: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
• 17. Kowalska A., Kowalik A.: Telomeres and telomerase in oncogenesis. Wsp Onkol 2006, 10, 485-496.
• 18. Lechowski R., Żmudzka M.: Telomerase - main trends in research. Med Weter 2003, 59, 100-103.
• 19. Lo A.W., Sabatier L., Fouladi B., Pottier G., Ricoul M., Murnane J.P.: DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia 2002, 4, 531-538.
• 20. McClintock B.: The stability of broken ends of chromosomes in Zeamays. Genetics 1941, 26, 234-282.
• 21. Mokbel K., Parris C.N., Ghilchik M., Williams G., Newbold R.F.: The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg 1999, 178, 69-72.
• 22. Muller H.J.: The remaking of chromosomes. Collecting Net 1938, 8, 182-195.
• 23. Muntoni A., Reddel R.R.: The first molecular details of ALT in human tumor cells. Hum Mol Genet 2005, 2, 191-196.
• 24. Nasir L., Devlin P., McKevitt T., Rutteman G., Argyle D.J.: Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology. Neoplasia 2001, 3, 351-359.
• 25. Nasir L., Gault E., Campbell S., Veeramalai M., Gilbert D., McFarlane R., Munro A., Argyle D.J.: Isolation and expression of the reverse transcriptase component of Canis familiaris telomerase ribonucleoprotein (dogTERT). Gene 2004, 336, 105-113.
• 26. O'Hagan R.C., Chang S., Maser R.S., Mohan R., Artandi S.E., Chin L., DePinho R.A.: Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2002, 2, 149-155.
• 27. Olovnikov A.M.: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973, 41, 181-190.
• 28. Panarese S., Brunetti B., Sarli G.: Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay. J Vet Diagn Invest 2006, 18, 362-368.
• 29. Reddel R.R.: The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000, 21, 477-484.
• 30. Remmele W., Stegner H.E.: Vorschlag zur einheitlichen Definition eines immunoreaktiven Score (IRS) für den immunohistochemichen Oestrogenrezeptornachweises (ER-ICA) im Mamma-karzinomgewebe. Pathologe 1987, 8, 138-140.
• 31. Rhyu M.S.: Telomeres, telomerase and immortality. J Natl Cancer Inst 1995, 87, 884-894.
• 32. Saito K., Yagihashi A., Nasu S., Izawa Y., Nakamura M., Kobayashi D., Tsuji N., Watanabe N.: Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer. Jpn J Cancer Res 2002, 93, 253-258.
• 33. Shay J.W., Bacchetti S.: A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33, 787-791.
• 34. Shay J.W., Roninson I.B.: Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004, 23, 2919-2933.
• 35. Shay J.W., Wright W.E.: Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006, 5, 577-584.
• 36. Umbricht C.B., Sherman M.E., Dome J., Carey L.A., Marks J., Kim N., Sukumar S.: Telomerase activity in ductal carcinoma in situ and invasive breast cancer. Oncogene 1999, 22, 3407-3414.